NCT03494114View on ClinicalTrials.gov

Imaging Activated Macrophages in the Lungs

PHASE1TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 29, 2018

Primary Completion Date

November 20, 2019

Study Completion Date

January 13, 2021

Conditions
COPD
Interventions
DRUG

Ga-EC2115

Ga-EC2115 will be administered by IV injection prior to PET/CT imaging.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

Sponsors

Collaborators (1)

Endocyte
All Listed Sponsors
collaborator

Endocyte

INDUSTRY

lead

Vanderbilt University Medical Center

OTHER